Healthcare -
Biotechnology - NASDAQ - US
$ 10.105
3.11 %
$ 50.9 M
Market Cap
-0.5
P/E
ALVR - TOTAL EQUITY
Total Equity ALVR - AlloVir, Inc.
146 M
LAST VALUE
-19.55%
2 YEAR CAGR
46.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR